When Insomnia and Sleep Apnea Coexist
Insomnia and obstructive sleep apnea (OSA) can occur in the same person. When they do, treating one while overlooking the other can leave important symptoms or barriers unexplained. Research on combined care is growing, but trials do not establish a universal order for CBT-I and apnea treatment. The practical starting point is a careful assessment of both conditions and a plan shaped around the person.
What the evidence supports
- Insomnia symptoms can coexist with OSA; each deserves its own assessment rather than assuming one explains the other.
- CBT-I can improve insomnia outcomes in adults being treated for OSA, including in trials that studied sequential or concurrent care.
- One randomized trial found improved subsequent positive airway pressure (PAP) acceptance and use after CBT-I; another found insomnia improvement but no PAP-adherence advantage.
What remains uncertain
- Which condition to address first depends on symptoms, safety, access, patient priorities, and the specific clinical situation.
- Trial participants, apnea severity, treatment protocols, and follow-up differed; study results should not be treated as a single sequencing rule.
- Evidence is still developing on how best to coordinate care across clinics and patient subgroups.
Evidence last reviewed: October 6, 2026. Conclusions may change as new research is published.
What COMISA means—and does not mean
COMISA is shorthand for comorbid insomnia and sleep apnea. It describes overlap, not a separate diagnosis with one fixed cause or treatment. A person may have difficulty falling asleep, repeated waking, early waking, or persistent nonrestorative sleep, alongside signs of obstructed breathing during sleep. Those experiences can influence each other, but having one does not prove the other is present.
The overlap is easy to miss when a visit is organized around one symptom. A person evaluated for apnea may also be spending long stretches awake and worried in bed. A person seeking help for insomnia may not volunteer snoring, witnessed breathing pauses, or gasping—or may sleep alone and have no observer. Neither pattern can be resolved by assuming apnea is “just insomnia” or that every insomnia symptom will disappear once breathing is treated.
This page stays with recognition and coordinated treatment. For apnea symptoms, risk assessment, and testing approaches, see the site's Sleep Apnea topic. For a focused look at sleep-related distress when reported sleep and recordings differ, see When Sleep Feels Shorter Than It Is.
Assess each condition on its own terms
A useful evaluation starts with the person's own account and a relevant medical and sleep history. The clinician asks about sleep initiation and maintenance, frequency and duration of the problem, daytime effects, schedule, medications and substances, and symptoms that could indicate breathing-related sleep disruption. A diary may help show patterns; a validated sleep test is considered when apnea is suspected. A wearable estimate cannot rule OSA in or out.
| Concern to assess | What it prompts | How to interpret it |
|---|---|---|
| 🛏️ Insomnia symptoms | Ask about sleep-onset or maintenance difficulty, distress, daytime impact, duration, and patterns across nights. | Subjective symptoms are central to the insomnia evaluation; a sleep study is not a required proof of distress. |
| 🌬️ Breathing symptoms | Review snoring, witnessed pauses, choking or gasping, sleepiness, and relevant medical history. | These may lead to an apnea evaluation; symptoms and risk factors are not themselves a diagnosis. |
| 📋 Daytime effects | Clarify fatigue, sleepiness, attention, mood, and safety-sensitive responsibilities. | Similar daytime complaints can have different contributors and deserve context. |
| 🧩 Other contributors | Consider pain, restless legs, mood symptoms, medication effects, caregiving, or schedule disruption. | Several factors may coexist; one label need not explain the entire picture. |
In COMISA, assessment can require coordination between primary care, sleep medicine, behavioral sleep medicine, and other clinicians. Each professional may hold only part of the history. Sharing a diary, sleep-test report, current treatment, and specific goals can help connect the pieces, with the patient's permission.
- 📝 Bring the insomnia pattern: note approximate bed and rise times, awakenings you recall, how often the problem occurs, and the effect on daytime life. Mark whether sleep opportunity was available or interrupted.
- 🌬️ Share breathing observations: mention snoring, choking or gasping, pauses noticed by someone else, prior test reports, and any treatment already tried. Sleeping alone may mean no witness is available; it does not settle the assessment.
- 📄 Keep the records in their lanes: a diary describes the person's experience across days; a sleep study is interpreted for the clinical question it was ordered to answer. Neither should dismiss symptoms reported in the other.
It can help to name the decisions that feel urgent: whether breathing treatment should start now, what might reduce insomnia-related barriers, and which clinician will follow each outcome. Separate questions support one coordinated plan without forcing everyone into the same sequence.
What the treatment trials actually compared
The clearest reason not to declare one sequence for everyone is that the trials asked different questions. Sweetman and colleagues randomized 145 people with OSA (apnea–hypopnea index at least 15) and comorbid insomnia to four CBT-I sessions or treatment as usual before starting CPAP. By six months, the CBT-I group averaged 61 more minutes of CPAP use per night than the comparison group, with a 95% confidence interval of 9 to 113 minutes; initial acceptance was 99% versus 89%. Insomnia severity improved more, but the trial found no between-group difference in sleep outcomes or daytime impairment at six months (Sweetman et al., Sleep, 2019).
MATRICS tested a different setup: 121 adults were assigned to CBT-I followed by PAP, CBT-I delivered concurrently with PAP, or PAP alone. The combined approaches improved insomnia outcomes compared with PAP alone, but did not significantly improve PAP adherence. The sequential and concurrent approaches did not differ significantly from one another on the measured outcomes (Ong et al., Sleep, 2020). These findings support treating insomnia alongside OSA; they do not show that delaying apnea treatment is preferable, or that every patient should receive CBT-I first.
The difference in results is not a contradiction that can be erased with a slogan. Populations, treatment comparisons, follow-up windows, and adherence outcomes differed. One study's result does not predict an individual patient's response, nor does a group-average difference guarantee that a specific person will use PAP more consistently.
Choosing a sequence is a clinical decision
Some people may begin PAP promptly while also starting CBT-I; others may address insomnia first, work on the two at the same time, or need another step before either treatment is workable. The balance can depend on apnea severity and symptoms, insomnia burden, daytime risk, preferences, treatment access, and the person's response. The trials support discussion of options rather than one rule that applies to all.
- 🎯 Agree on what will be tracked: insomnia severity, daytime functioning, and PAP use answer different questions. A single outcome should not stand in for the whole experience.
- 🧭 Make the plan feasible: discuss mask comfort or equipment concerns with the apnea-care team and sleep-related worry or awake time with a CBT-I clinician.
- 🔄 Reassess when the story changes: ongoing awakenings, worsening sleepiness, new breathing observations, or persistent insomnia can prompt a review of the original formulation.
⚠️ Don't postpone a breathing evaluation to test a theory
If a clinician suspects sleep apnea, ask what testing and treatment timing are appropriate for your specific situation. CBT-I can be relevant when OSA is present, but it does not diagnose or treat airway obstruction. Seek prompt clinical guidance for severe sleepiness or safety concerns.
Behavioral insomnia care with OSA in the picture
CBT-I can still address conditioned wakefulness, distress about sleep, and time awake in bed when OSA is also present. But components such as sleep-window adjustment may temporarily increase sleepiness. A clinician should account for the person's apnea evaluation, daytime alertness, work or driving demands, and other conditions before choosing the schedule. This is especially important if the person operates vehicles or machinery, provides overnight care, or has a history of a condition that can worsen with sleep loss.
Apnea treatment may also change how a night feels, but it should not be assumed to resolve all insomnia. Useful outcomes to assess extend beyond a pleasing graph: whether breathing-related concerns are appropriately managed, insomnia symptoms and distress change, and daytime life is safer and more manageable. For details of the treatment approaches specific to insomnia, read CBT-I: What Treatment Actually Involves.
Questions, answered briefly
- ❓ “If I have apnea, is insomnia secondary?” Not necessarily. The conditions may coexist and each can contribute to symptoms. Assessment should establish what is present rather than presume a single explanation.
- 🛌 “Must CBT-I happen before PAP?” No universal sequence follows from current trials. One trial found improved CPAP use after prior CBT-I; another found no adherence difference between sequential, concurrent, and PAP-only groups.
- 📋 “What can I bring to an appointment?” A concise sleep diary, observed breathing symptoms if available, prior sleep-test report, medications, and your main daytime concern can help the clinician decide what to assess next.
The Bottom Line
- Assess insomnia and possible apnea as separate but potentially overlapping problems. One should not automatically stand in for the other.
- CBT-I can help insomnia outcomes when OSA is also present. Trials support coordinated care, with differences in PAP-use results.
- No single treatment order fits everyone. The evidence tested different approaches and leaves sequencing to clinical context and shared decisions.
- Track more than one outcome. Breathing treatment, insomnia distress, daytime function, safety, and treatment feasibility all matter.
Related Topics
- Sweetman A, Lack L, Catcheside PG, et al., “Cognitive and Behavioral Therapy for Insomnia Increases the Use of Continuous Positive Airway Pressure Therapy in Obstructive Sleep Apnea Participants with Comorbid Insomnia: A Randomized Clinical Trial,” Sleep (2019). PubMed
- Ong JC, Crawford MR, Dawson SC, et al., “A Randomized Controlled Trial of CBT-I and PAP for Obstructive Sleep Apnea and Comorbid Insomnia: Main Outcomes from the MATRICS Study,” Sleep (2020). PubMed
- Edinger JD, Arnedt JT, Bertisch SM, et al., “Behavioral and Psychological Treatments for Chronic Insomnia Disorder in Adults,” Journal of Clinical Sleep Medicine (2021). DOI
- American Academy of Sleep Medicine, “Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults,” Journal of Clinical Sleep Medicine (2008). Full text
- American Academy of Sleep Medicine, “Obstructive Sleep Apnea” patient and clinical information. Sleep Education